ArticleScientific reports2016

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.

Gangadhara R Sareddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.